• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 EZH2 导致 AOX1 表达的表观遗传缺失导致代谢失调并促进膀胱癌进展。

Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

机构信息

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.

Dan L. Duncan Cancer Center, Advanced Technology Core, Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA.

出版信息

Oncogene. 2020 Oct;39(40):6265-6285. doi: 10.1038/s41388-019-0902-7. Epub 2019 Aug 5.

DOI:10.1038/s41388-019-0902-7
PMID:31383940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8058741/
Abstract

Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA and our findings demonstrate that AOX1 is epigenetically silenced during BLCA progression by the methyltransferase activity of EZH2. Knockdown (KD) of AOX1 in normal bladder epithelial cells re-wires the tryptophan-kynurenine pathway resulting in elevated NADP levels which may increase metabolic flux through the pentose phosphate (PPP) pathway, enabling increased nucleotide synthesis, and promoting cell invasion. Inhibition of NADP synthesis rescues the metabolic effects of AOX1 KD. Ectopic AOX1 expression decreases NADP production, PPP flux and nucleotide synthesis, while decreasing invasion in cell line models and suppressing growth in tumor xenografts. Further gain and loss of AOX1 confirm the EZH2-dependent activation, metabolic deregulation, and tumor growth in BLCA. Our findings highlight the therapeutic potential of AOX1 and provide a basis for the development of prognostic markers for advanced BLCA.

摘要

高级膀胱癌(BLCA)仍然是一个临床挑战,缺乏有效的治疗措施。在这里,我们表明,BLCA 中不同阶段的代谢改变与醛氧化酶(AOX1)功能丧失有关。与 AOX1 相关的代谢物对晚期 BLCA 具有很高的预测价值,我们的研究结果表明,在 BLCA 进展过程中,EZH2 的甲基转移酶活性使 AOX1 发生表观遗传沉默。在正常膀胱上皮细胞中敲低(KD)AOX1 会重新连接色氨酸-犬尿氨酸途径,导致 NADP 水平升高,这可能会增加戊糖磷酸(PPP)途径的代谢通量,从而促进核苷酸合成,并促进细胞侵袭。抑制 NADP 合成可挽救 AOX1 KD 的代谢效应。异位 AOX1 表达降低 NADP 生成、PPP 通量和核苷酸合成,同时降低细胞系模型中的侵袭,并抑制肿瘤异种移植物的生长。进一步获得和丧失 AOX1 证实了 EZH2 依赖性激活、代谢失调和 BLCA 中的肿瘤生长。我们的研究结果强调了 AOX1 的治疗潜力,并为开发晚期 BLCA 的预后标志物提供了依据。

相似文献

1
Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.通过 EZH2 导致 AOX1 表达的表观遗传缺失导致代谢失调并促进膀胱癌进展。
Oncogene. 2020 Oct;39(40):6265-6285. doi: 10.1038/s41388-019-0902-7. Epub 2019 Aug 5.
2
Re: Epigenetic Loss of AOX1 Expression via EZH2 Leads to Metabolic Deregulations and Promotes Bladder Cancer Progression.回复:通过EZH2导致AOX1表达的表观遗传缺失引发代谢失调并促进膀胱癌进展。
J Urol. 2020 Apr;203(4):666. doi: 10.1097/JU.0000000000000732.02. Epub 2020 Jan 13.
3
Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.长链非编码 RNA GAS5 通过抑制 EZH2 转录促进膀胱癌细胞凋亡。
Cell Death Dis. 2018 Feb 14;9(2):238. doi: 10.1038/s41419-018-0264-z.
4
The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.长链非编码 RNA SNHG1 通过与 miR-143-3p 和 EZH2 相互作用促进膀胱癌的进展。
J Cell Mol Med. 2020 Oct;24(20):11858-11873. doi: 10.1111/jcmm.15806. Epub 2020 Sep 4.
5
Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.E2F1 调控的 EZH2 和 SUZ12 激活预测膀胱癌的疾病进展和侵袭特征。
Clin Cancer Res. 2015 Dec 1;21(23):5391-403. doi: 10.1158/1078-0432.CCR-14-2680. Epub 2015 Aug 12.
6
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.PIK3CA基因改变在非肌层浸润性膀胱癌中对EZH2信号传导的相反作用。
Oncotarget. 2017 Feb 7;8(6):10531-10542. doi: 10.18632/oncotarget.14453.
7
PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.PRMT5与EZH2在功能上相关联,通过表观遗传抑制CDKN2B的表达来促进结直肠癌进展。
Theranostics. 2021 Jan 27;11(8):3742-3759. doi: 10.7150/thno.53023. eCollection 2021.
8
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.从头嘌呤代谢酶 PAICS 在膀胱癌进展中的作用。
Neoplasia. 2018 Sep;20(9):894-904. doi: 10.1016/j.neo.2018.07.006. Epub 2018 Aug 15.
9
DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.DDX11-AS1 通过抑制 miR-499b-5p 增强 CDK6 表达促进膀胱癌进展。
Biomed Pharmacother. 2020 Jul;127:110164. doi: 10.1016/j.biopha.2020.110164. Epub 2020 May 15.
10
Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.厚朴酚通过抑制EZH2/miR-143轴来抑制膀胱肿瘤生长。
Oncotarget. 2015 Nov 10;6(35):37335-48. doi: 10.18632/oncotarget.6135.

引用本文的文献

1
GSK343, an inhibitor of EZH2, prevents acquired cisplatin resistance in bladder cancer.EZH2抑制剂GSK343可预防膀胱癌中获得性顺铂耐药。
Mol Genet Genomics. 2025 Jun 23;300(1):63. doi: 10.1007/s00438-025-02273-3.
2
Identification of Critical Molecular Pathways Induced by HDAC11 Overexpression in Cardiac Mesenchymal Stem Cells.心脏间充质干细胞中HDAC11过表达诱导的关键分子途径的鉴定
Biomolecules. 2025 May 3;15(5):662. doi: 10.3390/biom15050662.
3
Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer.

本文引用的文献

1
Bladder cancer: Genomics of noninvasive disease.膀胱癌:非侵袭性疾病的基因组学
Nat Rev Urol. 2018 Jan;15(1):1. doi: 10.1038/nrurol.2017.207. Epub 2017 Dec 5.
2
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.具有不同代谢特征及KDM6A突变频率存在女性性别偏向的非侵袭性膀胱癌的基因组亚型
Cancer Cell. 2017 Nov 13;32(5):701-715.e7. doi: 10.1016/j.ccell.2017.08.005.
3
Network-based pathway enrichment analysis with incomplete network information.基于网络的通路富集分析,网络信息不完整。
用于预测前列腺癌术后生化复发的色氨酸代谢相关风险模型及分子亚型的开发与验证
Transl Androl Urol. 2025 Apr 30;14(4):1082-1110. doi: 10.21037/tau-2025-39. Epub 2025 Apr 27.
4
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity.异柠檬酸脱氢酶(IDH)状态决定了单纯疱疹病毒(oHSV)介导的代谢重编程,影响抗肿瘤免疫。
Nat Commun. 2025 Apr 24;16(1):3874. doi: 10.1038/s41467-025-58911-2.
5
Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer.整合多队列机器学习与临床样本验证以探索前列腺癌的外周血mRNA诊断生物标志物。
Cancer Cell Int. 2025 Apr 22;25(1):158. doi: 10.1186/s12935-025-03788-w.
6
Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer.接触烟草烟雾是头颈部癌症中氧化应激反应和免疫改变的一个驱动因素。
J Transl Med. 2025 Apr 5;23(1):403. doi: 10.1186/s12967-025-06258-z.
7
Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk.分析DNA甲基化和转录组特征以预测前列腺癌复发风险。
Discov Oncol. 2025 Feb 1;16(1):110. doi: 10.1007/s12672-025-01833-8.
8
Machine learning-based pan-cancer study of classification and mechanism of BRAF inhibitor resistance.基于机器学习的BRAF抑制剂耐药性分类及机制的泛癌研究
Transl Cancer Res. 2024 Dec 31;13(12):6645-6660. doi: 10.21037/tcr-24-961. Epub 2024 Dec 27.
9
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.G9a/DNMT1 共靶向抑制非小细胞肺癌生长,并通过 SCARA5 和 AOX1 使肿瘤细胞重编程以响应癌症药物。
Cell Death Dis. 2024 Nov 2;15(11):787. doi: 10.1038/s41419-024-07156-w.
10
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer.非裔美国膀胱癌患者通过谷氨酰胺代谢激活 OXPHOS 进行线粒体重编程。
JCI Insight. 2024 Sep 10;9(17):e172336. doi: 10.1172/jci.insight.172336.
Bioinformatics. 2016 Oct 15;32(20):3165-3174. doi: 10.1093/bioinformatics/btw410. Epub 2016 Jun 29.
4
EZH2, an on-off valve in signal network of tumor cells.EZH2,肿瘤细胞信号网络中的一个开关阀。
Cell Signal. 2016 May;28(5):481-487. doi: 10.1016/j.cellsig.2016.02.004. Epub 2016 Feb 11.
5
Targeting EZH2 in cancer.在癌症中靶向EZH2
Nat Med. 2016 Feb;22(2):128-34. doi: 10.1038/nm.4036.
6
SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.SDPR通过促进细胞凋亡在乳腺癌中发挥转移抑制作用。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):638-43. doi: 10.1073/pnas.1514663113. Epub 2016 Jan 6.
7
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.分子途径:靶向吲哚胺2,3-双加氧酶1及其他色氨酸双加氧酶用于癌症免疫治疗
Clin Cancer Res. 2015 Dec 15;21(24):5427-33. doi: 10.1158/1078-0432.CCR-15-0420. Epub 2015 Oct 30.
8
The multifaceted functions of sirtuins in cancer.Sirtuins 在癌症中的多方面功能。
Nat Rev Cancer. 2015 Oct;15(10):608-24. doi: 10.1038/nrc3985. Epub 2015 Sep 18.
9
A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.TDO2-AhR信号轴促进三阴性乳腺癌的失巢凋亡抗性和转移。
Cancer Res. 2015 Nov 1;75(21):4651-64. doi: 10.1158/0008-5472.CAN-15-2011. Epub 2015 Sep 11.
10
Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia.癌症中的视黄酸信号传导:急性早幼粒细胞白血病的故事
Int J Cancer. 2014 Nov 15;135(10):2262-72. doi: 10.1002/ijc.29081. Epub 2014 Aug 14.